New Delhi: India is exporting critical drugs like hydroxychloroquine, paracetamol as well as azithromycin to over 20 countries to aid the fight against the Covid-19 pandemic, ThePrint has learnt.
From the US in the west to Bangladesh in the east, these drugs are being exported to more than 20 countries in two categories – commercial and humanitarian aid, said sources.
According to sources, India will be exporting these drugs to US, Brazil, Spain, Germany, Bahrain, Nepal, Bhutan, Afghanistan, Maldives, Bangladesh, Seychelles, Mauritius, Dominican Republic, Israel, Canada, UK, France, Australia, New Zealand and some other African countries, including South Africa.
While the Modi government is planning to donate these drugs to some countries in SAARC, Africa and Latin America, it will be selling them to countries like the US and a few European countries.
“We are in the process of providing humanitarian aid in the form of pharmaceutical and other items, including HCQ & paracetamol … We are processing requests for medicines from other countries based on availability. These would be supplied on a commercial basis,” said a source.
Medicines will be sent in batches
The medicines will be sent in batches to these countries over a certain period of time based on when the order was placed by them and emergency situations in certain countries.
We are deeply grateful to our readers & viewers for their time, trust and subscriptions.
Quality journalism is expensive and needs readers to pay for it. Your support will define our work and ThePrint’s future.
The countries that had put in requests in early March will get the first batch of consignment and eventually, it will be sent to all others who have requested the drugs.
“A lot of requests for HCQ (hydroxychloroquine) were already there and taking into view domestic stock and requirement while keeping a sufficient buffer, a decision was taken by the Group of Ministers to release some of the surplus medicine for export purposes,” said Dammu Ravi, Additional Secretary and Covid Coordinator, Ministry of External Affairs.
He added that the country has more than three times the supply of hydroxychloroquine that is needed for domestic consumption.
Earlier this week, US President Donald Trump had said the US has 30 million doses of hydroxychloroquine, some which was procured from India.
“I want to thank Prime Minister Modi of India for allowing us to have what we requested from before the problem arose. And he was — he was terrific. We’ll remember it,” said Trump during a White House press briefing Wednesday.
Israel Prime Minister Benjamin Netanyahu and Brazilian President Jair Bolsonaro have also thanked Prime Minister Narendra Modi, along with a few other world leaders, for sending hydroxychloroquine, an anti-malaria drug that is believed to be effective in curing Covid-19.
“Thank you government of India, for approving Maldives’ request for Hydroxychloroquine, which is being called a game changer in the fight against #Covid19. A friend in need is truly a friend indeed!,” tweeted Abdulla Shahid, foreign minister of Maldives.
Thank you government of India, for approving Maldives’ request for Hydroxychloroquine, which is being called a game changer in the fight against #Covid19. A friend in need is truly a friend indeed! @narendramodi @DrSJaishankar@MEAIndia
— Abdulla Shahid (@abdulla_shahid) April 10, 2020
News media is in a crisis & only you can fix it
You are reading this because you value good, intelligent and objective journalism. We thank you for your time and your trust.
You also know that the news media is facing an unprecedented crisis. It is likely that you are also hearing of the brutal layoffs and pay-cuts hitting the industry. There are many reasons why the media’s economics is broken. But a big one is that good people are not yet paying enough for good journalism.
We have a newsroom filled with talented young reporters. We also have the country’s most robust editing and fact-checking team, finest news photographers and video professionals. We are building India’s most ambitious and energetic news platform. And we aren’t even three yet.
At ThePrint, we invest in quality journalists. We pay them fairly and on time even in this difficult period. As you may have noticed, we do not flinch from spending whatever it takes to make sure our reporters reach where the story is. Our stellar coronavirus coverage is a good example. You can check some of it here.
This comes with a sizable cost. For us to continue bringing quality journalism, we need readers like you to pay for it. Because the advertising market is broken too.
If you think we deserve your support, do join us in this endeavour to strengthen fair, free, courageous, and questioning journalism, please click on the link below. Your support will define our journalism, and ThePrint’s future. It will take just a few seconds of your time.